Jane Street’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $761K | Buy |
+804,667
| New | +$761K | ﹤0.01% | 3191 |
|
|
2025
Q1 | – | Sell |
-220,264
| Closed | -$163K | – | 6172 |
|
|
2024
Q4 | $163K | Buy |
220,264
+134,903
| +158% | +$99.6K | ﹤0.01% | 5179 |
|
|
2024
Q3 | $134K | Sell |
85,361
-44,495
| -34% | -$69.9K | ﹤0.01% | 5381 |
|
|
2024
Q2 | $218K | Sell |
129,856
-151,732
| -54% | -$255K | ﹤0.01% | 5313 |
|
|
2024
Q1 | $676K | Buy |
281,588
+9,221
| +3% | +$22.1K | ﹤0.01% | 3695 |
|
|
2023
Q4 | $417K | Buy |
272,367
+190,437
| +232% | +$291K | ﹤0.01% | 4316 |
|
|
2023
Q3 | $89.3K | Buy |
81,930
+61,382
| +299% | +$66.9K | ﹤0.01% | 4658 |
|
|
2023
Q2 | $47.1K | Sell |
20,548
-22,975
| -53% | -$52.6K | ﹤0.01% | 4950 |
|
|
2023
Q1 | $106K | Buy |
43,523
+26,192
| +151% | +$63.6K | ﹤0.01% | 4932 |
|
|
2022
Q4 | $33.1K | Sell |
17,331
-17,210
| -50% | -$32.9K | ﹤0.01% | 4961 |
|
|
2022
Q3 | $83K | Buy |
+34,541
| New | +$83K | ﹤0.01% | 4959 |
|
|
2022
Q2 | – | Sell |
-19,723
| Closed | -$41K | – | 5976 |
|
|
2022
Q1 | $41K | Sell |
19,723
-18,744
| -49% | -$39K | ﹤0.01% | 5195 |
|
|
2021
Q4 | $152K | Sell |
38,467
-1,253
| -3% | -$4.95K | ﹤0.01% | 4512 |
|
|
2021
Q3 | $191K | Buy |
39,720
+24,509
| +161% | +$118K | ﹤0.01% | 4421 |
|
|
2021
Q2 | $70K | Sell |
15,211
-7,465
| -33% | -$34.4K | ﹤0.01% | 4857 |
|
|
2021
Q1 | $133K | Buy |
+22,676
| New | +$133K | ﹤0.01% | 4461 |
|
|
2020
Q4 | – | Sell |
-12,011
| Closed | -$17K | – | 4191 |
|
|
2020
Q3 | $17K | Sell |
12,011
-6,136
| -34% | -$8.69K | ﹤0.01% | 3670 |
|
|
2020
Q2 | $36K | Buy |
+18,147
| New | +$36K | ﹤0.01% | 3820 |
|
|
2020
Q1 | – | Sell |
-13,991
| Closed | -$58K | – | 3744 |
|
|
2019
Q4 | $58K | Sell |
13,991
-47,175
| -77% | -$196K | ﹤0.01% | 3140 |
|
|
2019
Q3 | $184K | Buy |
+61,166
| New | +$184K | ﹤0.01% | 3079 |
|
|
2014
Q1 | – | Sell |
-6,409
| Closed | -$81K | – | 2604 |
|
|
2013
Q4 | $81K | Buy |
6,409
+2,810
| +78% | +$35.5K | ﹤0.01% | 1944 |
|
|
2013
Q3 | $60K | Buy |
+3,599
| New | +$60K | ﹤0.01% | 2300 |
|